The biopharmaceutical industry ’s unique role in responding to COVID-19
As the outbreak of COVID-19, a disease caused by a novel strain of coronavirus, evolves in the United States and around the globe, both the private and public sectors are working around the clock to find solutions. America ’s biopharmaceutical companies areworking tirelessly to develop ways to diagnose, prevent and treat those with coronavirus.
Source: The Catalyst - Category: Pharmaceuticals Authors: Richard Moscicki, M.D. Tags: Research and Development PhRMA Member Company Clinical Trials Infectious Diseases Coronavirus Source Type: news
More News: Clinical Trials | Coronavirus | COVID-19 | Infectious Diseases | Outbreaks | Pharmaceuticals | USA Health